Laila C. Roisman
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 13
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 8
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 7
- Cytokine Signaling Pathways and Interactions 4
- Immunology top 5%
- interferon and immune responses 3
-
- Lung Cancer Treatments and Mutations 23
- Lung Cancer Diagnosis and Treatment 5
- Molecular Biology top 10%
- Co-authors
- Gideon SchreiberJacob PiehlerDiego Adhemar JaitinNir PeledRoberto CappaiZvi LivnehDalia ElingerZiv Sevilya
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)
- Partner nations
- IsraelUnited StatesAustralia
In The Last Decade
Laila C. Roisman
45 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 495
- Oncology 776
- Immunology 593
- Pulmonary and Respiratory Medicine 802
- Molecular Biology 810
Countries citing papers authored by Laila C. Roisman
This map shows the geographic impact of Laila C. Roisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laila C. Roisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laila C. Roisman more than expected).
Fields of papers citing papers by Laila C. Roisman
This network shows the impact of papers produced by Laila C. Roisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laila C. Roisman. The network helps show where Laila C. Roisman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laila C. Roisman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 25 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 0 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 16 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 1 | |
| 13 | 2018 | 1 | |
| 14 | 2018 | 3 | |
| 15 | 2018 | 8 | |
| 16 | 2013 | 170 | |
| 17 | 2011 | 108 | |
| 18 | 2006 | 193 | |
| 19 | 2005 | 69 | |
| 20 | 2004 | 18 |
About Laila C. Roisman
Laila C. Roisman is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 50 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Cancer Genomics and Diagnostics (13 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Research Studies (7 papers), Lung Cancer Diagnosis and Treatment (5 papers), Cytokine Signaling Pathways and Interactions (4 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Cancer Research (495 citations), Oncology (776 citations) and Immunology (593 citations). Laila C. Roisman has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Gideon Schreiber, Jacob Piehler, Diego Adhemar Jaitin, Nir Peled, Roberto Cappai, Zvi Livneh, Dalia Elinger, Ziv Sevilya, Yael Leitner‐Dagan and Tamar Paz-Elizur. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.